Verrica Pharmaceuticals Inc. Financial Ratios — VRCA Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-92.64	-40.89	-35.19	-59.89	-45.48	-39.23	-106.07	-112.84	-35.33
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	100	91.97	85.44	63.79	90.33
EBITDA Margin (%)	- -	- -	- -	- -	- -	-253.63	-227.83	-1,217.53	-853.38	-31.36
Operating Margin (%)	- -	- -	- -	- -	- -	-257.57	-235.78	-1,233.84	-870.16	-33.56
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-292.33	-271.11	-1,307.47	-1,012.15	-50.27
Profit Margin (%)	- -	- -	- -	- -	- -	-292.33	-271.11	-1,307.47	-1,012.15	-50.27
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-292.33	-271.11	-1,307.47	-1,012.15	-50.27
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	54.31	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	37	43	2	46	46	2
ST Debt	- -	- -	- -	- -	36	42	- -	1	14	1
LT Debt	- -	- -	- -	- -	2	1	1	45	32	1
Total Debt/EBITDA	- -	- -	- -	-0.01	-0.93	-1.43	-0.07	-0.73	-0.71	-0.15
Net Debt/EBITDA	0.28	1.94	0.47	0.31	-0.62	-0.85	1.67	0.43	0.04	2.7
Total Debt/EBIT	- -	- -	- -	-0.01	-0.93	-1.4	-0.07	-0.72	-0.7	-0.14
Net Debt/EBIT	0.28	1.94	0.47	0.31	-0.61	-0.84	1.61	0.42	0.04	2.53
EBITDA to Interest Expense	- -	-2,228.5	- -	- -	-13.17	-7.09	-9.47	-15.75	-6.86	-1.44
EBITDA-CapEx/Interest Expense	- -	-2,228.5	- -	- -	-13.65	-7.29	-9.61	-15.84	-6.86	-1.44
EBIT to Interest Expense	- -	-2,228.5	- -	- -	-13.24	-7.2	-9.8	-15.96	-6.99	-1.54
Interest Expense	- -	- -	- -	- -	3	4	2	4	9	8
Common Equity/Total Assets	-491.91	-136.9	-35.99	-89.43	-140.09	-173.43	-365.49	-282.42	-567.16	-689.38
Long-Term Debt/Equity (%)	- -	- -	- -	0.09	5.13	4.49	3.07	226.74	- -	3.58
Long-Term Debt/Capital (%)	- -	- -	- -	-0.1	-2.54	-1.53	-0.76	-24.23	-12.38	-0.27
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.08	2.28	1.83	2.75	54.92	59.73	1.88
Total Debt/Equity (%)	- -	- -	- -	0.29	112.79	133.14	3.81	230.28	-465.91	6.59
Total Debt/Capital (%)	- -	- -	- -	-0.31	-55.8	-45.43	-0.94	-24.61	-17.6	-0.5
Total Debt/Total Assets (%)	- -	- -	- -	0.27	50.17	54.18	3.41	55.77	84.86	3.46
Net Debt to Equity	19.78	123.04	-11.49	-14.21	74.67	79.56	-85.61	-134.96	24.42	-121.84
Net Debt/Capital (%)	127.29	41.06	23.69	13.16	-31.84	-23.31	17.47	10.48	0.78	8.53
EBITDA	-2	-4	-22	-30	-40	-30	-21	-62	-65	-11
EBITDA-CapEx	-2	-4	-23	-31	-41	-31	-21	-63	-65	-11
Operating Income (Loss)	-2	-4	-22	-30	-40	-31	-21	-63	-66	-12

Liquidity (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.26	14.06	36.26	18.51	1.66	1.53	9.91	4.09	1.6	1.83
Current Ratio	1.3	14.75	36.8	19.39	1.71	1.61	11.31	4.55	1.76	2.59
Quick Ratio	1.26	14.06	36.26	18.51	1.66	1.53	10.05	4.34	1.6	2.16
CFO/Avg Current Liab	- -	-8.86	-11.56	-9.41	-1.41	-0.64	-0.75	-3.77	-2.65	-0.78
Common Equity/Total Assets	-491.91	-136.9	-35.99	-89.43	-140.09	-173.43	-365.49	-282.42	-567.16	-689.38
Long-Term Debt/Equity (%)	- -	- -	- -	0.09	5.13	4.49	3.07	226.74	- -	3.58
Long-Term Debt/Capital (%)	- -	- -	- -	-0.1	-2.54	-1.53	-0.76	-24.23	-12.38	-0.27
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.08	2.28	1.83	2.75	54.92	59.73	1.88
Total Debt/Equity (%)	- -	- -	- -	0.29	112.79	133.14	3.81	230.28	-465.91	6.59
Total Debt/Capital (%)	- -	- -	- -	-0.31	-55.8	-45.43	-0.94	-24.61	-17.6	-0.5
Total Debt/Total Assets (%)	- -	- -	- -	0.27	50.17	54.18	3.41	55.77	84.86	3.46
CFO/Total Liabilities	-50.22	-28.42	-721.6	-803.99	-73.37	-58.04	-397.82	-62.39	-95.21	-78.73
CFO/CapEx	- -	- -	-23.09	-40.19	-20.55	-31.24	-61.75	-106.57	-2,256.56	- -
Altman's Z-Score	-18.22	-2.42	28.81	68.01	0.9	- -	6.49	-2.34	-10.98	-6.7

Working Capital (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	46.56	2.21	3.52	13.41
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	7.84	165.12	103.62	27.23
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	1.46	1.57	1.46
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	250.02	232.12	249.22
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	1.07	1.19	1.92	1.62
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	340.33	306.68	190.31	225.31
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	-332.49	108.46	145.43	51.13
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	7.84	-84.9	-128.5	-221.99
Inventories	- -	- -	- -	- -	- -	- -	- -	1	2	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	1	1
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	1	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	120	396	288	248	94	332	36	89
- Cash & Cash Equivalents	1	9	10	9	11	16	34	70	46	30
+ Preferred Equity and Hybrid Capital	3	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	37	43	2	46	46	2
Enterprise Value	2	-9	30	334	259	221	61	308	36	60
Total Capital	- -	-12	-33	-61	-67	-96	-162	-185	-261	-323
Total Debt/Capital (%)	- -	- -	- -	-0.31	-55.8	-45.43	-0.94	-24.61	-17.6	-0.5
Total Debt / EV	- -	- -	- -	- -	0.14	0.2	0.02	0.15	1.28	0.03
EV/Sales	- -	- -	- -	- -	- -	18.4	6.78	60.08	4.74	1.69
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	120	396	288	248	94	332	36	89
Diluted Enterprise Value	2	-9	109	387	314	275	61	308	36	60
EV per Share	1.13	- -	20.25	134.07	103.79	81.64	17.91	67.9	6.92	5.63
TTM Sales	- -	- -	- -	- -	- -	12	9	5	8	36
TTM EBITDA	-2	-4	-22	-30	-40	-30	-21	-62	-65	-11
TTM Operating Income	-2	-4	-22	-30	-40	-31	-21	-63	-66	-12
TTM Cash Flow to Firm	-2	-5	-18	-27	-27	-23	-16	-35	-52	-10
TTM Free Cash Flow to Firm	-2	-5	-17	-27	-26	-22	-16	-34	-51	-10

Multiples (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-6.99	-14.8	-10.01	-9.28	-5.12	-8.69	-0.6	-5.02
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	-9	30	334	259	221	61	308	36	60
Low Price	- -	- -	64.4	68.4	60.2	85.1	17.7	27.7	6.11	3.28
EV/Sales	- -	- -	- -	- -	- -	18.4	6.78	60.08	4.74	1.69
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-10.66	-10.34	-6.15	-9.33	-6.73	-3.6	-3.17	-3.48
Price/Earnings High	- -	- -	-16.54	-16.48	-10.3	-14.2	-13.74	-5.89	-7.72	-5.85
Price/Earnings Low	- -	- -	-4.57	-6.04	-3.52	-6.56	-2.47	-1.87	-0.41	-1.95
Price/Book Value	- -	- -	-3.61	-6.47	-2.77	-1.78	-0.57	-1.44	-0.12	-0.27
Price/Book Value Average	- -	- -	-6.65	-4.77	-2.53	-2.36	-1.01	-1.05	-0.79	-0.19
Price/Book Value High	- -	- -	-10.32	-7.6	-4.23	-3.58	-2.06	-1.71	-1.93	-0.32
Price/Book Value Low	- -	- -	-2.85	-2.78	-1.45	-1.66	-0.37	-0.55	-0.1	-0.11
Price/Tangible Book Value	- -	- -	1.34	6.09	8.72	7.6	2.35	16.79	-3.68	3.58
Price/Tangible Book Value Average	- -	- -	2.46	4.49	7.96	10.04	4.11	12.21	-24.59	2.52
Price/Tangible Book Value High	- -	- -	3.82	7.15	13.34	15.28	8.41	19.96	-59.95	4.23
Price/Tangible Book Value Low	- -	- -	1.06	2.62	4.56	7.06	1.51	6.36	-3.21	1.41
Price/Sales	- -	- -	- -	- -	- -	20.64	10.4	64.77	4.79	2.49
Price/Sales Average	- -	- -	- -	- -	- -	27.27	18.23	47.09	32.04	1.75
Price/Sales High	- -	- -	- -	- -	- -	41.51	37.26	76.99	78.13	2.94
Price/Sales Low	- -	- -	- -	- -	- -	19.18	6.7	24.51	4.18	0.98
Price/Cash Flow	- -	- -	-6.69	-14.43	-9.52	-8.98	-5.04	-8.6	-0.6	-5.02
Price/Cash Flow Average	- -	- -	-12.31	-10.64	-8.69	-11.87	-8.83	-6.26	-3.98	-3.53
Price/Cash Flow High	- -	- -	-19.11	-16.96	-14.56	-18.06	-18.04	-10.23	-9.7	-5.93
Price/Cash Flow Low	- -	- -	-5.28	-6.21	-4.98	-8.34	-3.24	-3.26	-0.52	-1.98
Price/Free Cash Flow Average	- -	- -	-12.87	-10.91	-9.13	-12.26	-8.98	-6.31	-3.98	-3.53
Price/Free Cash Flow High	- -	- -	-19.97	-17.39	-15.31	-18.66	-18.34	-10.32	-9.71	-5.93
Price/Free Cash Flow Low	- -	- -	-5.52	-6.37	-5.24	-8.62	-3.3	-3.29	-0.52	-1.98
EV/Sales Average	- -	- -	- -	- -	- -	29.58	14.61	42.4	31.99	0.95
EV/Sales High	- -	- -	- -	- -	- -	43.82	33.63	72.3	78.08	2.14
EV/Sales Low	- -	- -	- -	- -	- -	21.48	3.07	19.82	4.13	0.18
EV/EBITDA Average	-1.18	1.94	-9.6	-9.48	-7.23	-11.66	-6.41	-3.48	-3.75	-3.03
EV/EBITDA High	-1.18	1.94	-15.15	-15.28	-11.68	-17.28	-14.76	-5.94	-9.15	-6.82
EV/EBITDA Low	-1.18	1.94	-3.85	-5.41	-4.43	-8.47	-1.35	-1.63	-0.48	-0.58
EV/EBIT Average	-1.18	1.94	-9.59	-9.4	-7.19	-11.48	-6.2	-3.44	-3.68	-2.83
EV/EBIT High	-1.18	1.94	-15.14	-15.15	-11.61	-17.01	-14.26	-5.86	-8.97	-6.37
EV/EBIT Low	-1.18	1.94	-3.85	-5.36	-4.4	-8.34	-1.3	-1.61	-0.47	-0.54
Last Price	- -	- -	81.5	158.9	115.1	91.6	27.5	73.2	7	8.31
High Price	- -	- -	232.9	186.7	176	184.2	98.5	87	114.1	9.82
Enterprise Value Average	2	-9	210	283	289	355	132	217	242	34
Enterprise Value High	2	-9	331	456	466	526	304	370	591	76
Enterprise Value Low	2	-9	84	161	177	258	28	102	31	6

Shares Outstanding	2	2	3	3	3	3	4	4	9	17
Diluted Weighted Avg Shares	2	2	1	2	2	3	3	5	5	11
Basic Weighted Avg Shares	2	2	1	2	2	3	3	5	5	11
Revenue per Share	- -	- -	- -	- -	- -	4.44	2.64	1.13	1.46	3.34
EBITDA per Share	-0.96	-2.23	-14.91	-11.98	-15.98	-11.25	-6.02	-13.76	-12.46	-1.05
Operating Income per Share	-0.96	-2.23	-14.92	-12.08	-16.08	-11.43	-6.23	-13.94	-12.71	-1.12
Basic EPS, GAAP	-0.96	-4.89	-14.08	-11.33	-17.08	-12.97	-7.17	-14.78	-14.78	-1.68
Basic EPS from Cont Ops	-0.96	-2.24	-14.08	-11.33	-17.08	-12.97	-7.17	-14.78	-14.78	-1.68
Diluted EPS, GAAP	-0.96	-4.89	-14.08	-11.33	-17.08	-12.97	-7.17	-14.78	-14.78	-1.68
Diluted EPS from Cont Ops	-0.96	-2.24	-14.08	-11.33	-17.08	-12.97	-7.17	-14.78	-14.78	-1.68
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.81	-2.3	-12.19	-11.01	-12.08	-10.2	-5.46	-8.51	-11.76	-1.65
Free Cash Flow per Basic Share	-0.81	-2.3	-12.72	-11.28	-12.67	-10.53	-5.55	-8.59	-11.77	-1.65
Cash & Equivalents per Share	0.26	4.34	61.25	24.91	26.19	26.01	10.03	15.34	8.94	2.83
Book Value per Share	-1.34	-6.23	-22.56	-24.58	-41.56	-51.38	-47.84	-50.82	-59.26	-30.5
Tangible Book Value per Share	-2.73	-3.53	60.99	26.11	13.2	12.06	11.72	4.36	-1.9	2.32

Verrica Pharmaceuticals Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)